COVID-19: For information related to COVID-19 (formerly referred to as “novel coronavirus"), visit

VCU Massey Cancer Center


Massey doctor honored by the American Society for Radiation Oncology

[View Image]
Leland Rogers, M.D.

Massey physician Leland Rogers, M.D., was recently awarded the Fellows designation by the American Society for Radiation Oncology (ASTRO) at the society’s 57th Annual Meeting on October 20 in San Antonio, TX. Rogers is a radiation oncologist and member of the Radiation Biology and Oncology research program at Virginia Commonwealth University Massey Cancer Center.

“I am flattered to be listed among my distinguished colleagues in the field of radiation oncology who have received this designation,” says Rogers. 

Rogers was one of 17 fellows honored this year and one of 59 to receive the designation since its inception in 2006. To be considered for the award, nominees must have been an active or emeritus member of ASTRO for at least 15 years, given the equivalent of 10 years of service to ASTRO and contributed significantly to the field of radiation oncology in the areas of research, education, patient care or service and leadership.

“It has been a great privilege to work alongside Dr. Rogers. This award affirms his commitment to his patients, which drives him to discover new and better ways to administer radiation therapy that delivers the best possible results with the least amount of side effects,” says Mitchell Anscher, M.D., chair and professor of the Department of Radiation Oncology and co-leader of the Radiation Biology and Oncology research program at Massey.

Rogers attended medical school at the University of Kentucky and completed his residency at the University of North Carolina Hospital Chapel Hill. His medical internship was served at Banner Good Samaritan Medical Center in Phoenix, Arizona. At Massey Cancer Center, Rogers is an expert in the field of brachytherapy, and specializes in the treatment of prostate and brain cancers. He also treats meningiomas and provides radiation therapy for non-malignant diseases.

To learn more about ASTRO and the Fellows designation, please visit

Written by: John Wallace

Posted on: October 26, 2015

Category: Center news & funding

View graphic versionView graphic versionView graphic version